GDRX Goodrx Holdings Inc
Company Analysis
Latest News
GoodRx enters Citi catalyst watch, capturing third of Wegovy pill market
Citi initiated a 30-day catalyst watch for GoodRx Holdings while maintaining a Buy rating and a $4 price target. The digital healthcare platform now captures...
GoodRx braces for impact, as Trump sets 200% generic drug tariffs
President Donald Trump announced a new tariff schedule for imported generic medications to incentivize domestic manufacturing. The policy implements zero...
🟢 GDRX is trading 5% up today, extending its recent rebound on momentum
GDRX is trading at $3.02 (up 5%), extending its recent rebound after several sessions of steady gains despite a lack of fresh company-specific news. • The...
🔴 GDRX is trading 6.3% down today as it slips from its recent rebound
GDRX is trading 6.3% down at $2.70 in pre-market, retreating from its recent rebound despite a lack of fresh, stock-specific headlines. • The move follows...
🔴 GDRX is trading 8.6% down today on low-liquidity extension of recent weakness
GDRX is trading at $2.35 (8.6% down) in thin pre-market action, appearing to be a sentiment-driven extension of recent selling pressure rather than a reaction...
🟢 Goodrx Holdings Inc is trading 9% up today in an isolated pre-market move
Goodrx Holdings Inc is trading 9% up at $2.90 in pre-market sessions, though the move appears to be an isolated, low-liquidity reaction as no fresh...
GDRX Stockholders Elect Three Directors and Approve All Proposals at Annual Meeting
GoodRx Holdings, Inc. announced the results of its 2026 Annual Meeting of Stockholders held on June 16, 2026. Shareholders voted to approve all proposals,...
🟢 Goodrx Holdings Inc is trading 5.9% up today on broad risk-on rally following tentative U.S.-Iran peace deal
Goodrx Holdings Inc is trading 5.9% up at $2.81 in pre-market as a broad risk-on rally lifts growth-oriented names following a tentative U.S.-Iran peace...